(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 5, Pages 1160
Publisher
MDPI AG
Online
2018-05-14
DOI
10.3390/molecules23051160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigallocatechin Gallate, a Green Tea Polyphenol Inhibits Mycobacterium smegmatis: In silico and In vitro Studies
- (2017) S Narayanan et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- Epigallocatechin gallate inhibits the growth of MDA-MB-231 breast cancer cells via inactivation of the β-catenin signaling pathway
- (2017) On-Yu Hong et al. Oncology Letters
- Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells
- (2017) Renate Wagner et al. Oncotarget
- Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer
- (2017) Ariadna Giró-Perafita et al. Oncotarget
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
- (2016) A. Giro-Perafita et al. CLINICAL CANCER RESEARCH
- Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
- (2016) Ramon Colomer et al. CURRENT DRUG TARGETS
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Triple-negative breast cancer: is there a treatment on the horizon?
- (2016) Hui Yao et al. Oncotarget
- Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
- (2016) Jingdan Qiu et al. Journal of Cancer
- Molecular Pathways: Fatty Acid Synthase
- (2015) S. F. Jones et al. CLINICAL CANCER RESEARCH
- Quercetin regulates β-catenin signaling and reduces the migration of triple negative breast cancer
- (2015) Asha Srinivasan et al. MOLECULAR CARCINOGENESIS
- Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
- (2015) Adriana Blancafort et al. PLoS One
- Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression
- (2015) Richard Ventura et al. EBioMedicine
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells
- (2014) Daniel Veigel et al. INTERNATIONAL JOURNAL OF CANCER
- Synthetic Inhibitors of Bacterial Cell Division Targeting the GTP-Binding Site of FtsZ
- (2013) Laura B. Ruiz-Avila et al. ACS Chemical Biology
- Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
- (2012) Joana Relat et al. BMC CANCER
- New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
- (2012) Carlos Turrado et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Flavonoids: Potential Wnt/beta-catenin signaling modulators in cancer
- (2011) Nathália G. Amado et al. LIFE SCIENCES
- Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer
- (2010) G. Oliveras et al. Annals of the New York Academy of Sciences
- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
- (2009) B. Corkery et al. ANNALS OF ONCOLOGY
- Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells
- (2009) Thomas W. Grunt et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity
- (2009) T. Puig et al. CLINICAL CANCER RESEARCH
- The Crystal Structure of a Mammalian Fatty Acid Synthase
- (2008) T. Maier et al. SCIENCE
- Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis
- (2007) Shailendra Kumar Sharma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started